Page last updated: 2024-10-21

tramiprosate and Pancreatic Neoplasms

tramiprosate has been researched along with Pancreatic Neoplasms in 1 studies

tramiprosate: GABA receptor agonist and a glycosaminoglycan mimetic; has nootropic acitivity; structure; a sulfonate analog of GABA
3-aminopropanesulfonic acid : An amino sulfonic acid that is the 3-amino derivative of propanesulfonic acid.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fragai, M1
Comito, G1
Di Cesare Mannelli, L1
Gualdani, R1
Calderone, V1
Louka, A1
Richichi, B1
Francesconi, O1
Angeli, A1
Nocentini, A1
Gratteri, P1
Chiarugi, P1
Ghelardini, C1
Tadini-Buoninsegni, F1
Supuran, CT1
Nativi, C1

Other Studies

1 other study available for tramiprosate and Pancreatic Neoplasms

ArticleYear
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX).
    Journal of medicinal chemistry, 2017, 11-09, Volume: 60, Issue:21

    Topics: Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Line, Tumor; Drug

2017